Imaging of cerebral ischemia within first hours: Computed tomography (CT);Imagerie de l'ischémie cérébrale dans les premières heures: Scanner

Journal de Radiologie

Volumn 86, Issue 9 II, 2005, Pages 1091-1104

  Januel, A C ^a   Tailleur, T ^a   Loubes Lacroix, F ^a   Catalaa, I ^a   Irsutti Fjortoft, M ^a   Molinier, S ^a   Tall, P ^a   Manelfe, C ^a   Cognard, C ^a  

^a CHU PURPAN   (France)

Author keywords

Brain, CT; Brain, ischemia; Brain, perfusion

Indexed keywords

FIBRINOLYTIC AGENT;

ARTERY OCCLUSION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; REVIEW; STROKE; UNIVERSITY HOSPITAL;

EID: 24044503793     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0221-0363(05)81499-4     Document Type: Review

References (29)

1. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999;354:1457-63.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissu plasminogen activator for acute ischemic stroke. N Engl Med 1995;333:1581-7.
3. Hacke W, Kaste M, Fieshi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51.
4. Grotta JC, Chiu D, Lu M et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous therapy. Stroke 1999;30:1528-33.
5. Clark WM, Wissman S, Albers GW et al. For the Alteplase Thrombolysis for Acute Non Interventionnal Therapy in Ischemic stroke. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. JAMA 1999;282: 2019-26.
6. Del Zopo GJ, Higashida RT, Furlan AJ et al. PROACT: a phase II randomised trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators: Prolyse in acute cerebral thromboembolism. Stroke 1998; 29:4-11.
7. Furlan AJ, Higashida RT, Wechsler L et al. Intra-arterial pro-urokinase for acute ischemic stroke: the PROACT II study: a randomised controlled trial. JAMA 1999;30:2003-11.
8. Duckwiller G. MERCI Trial. Endovascular today, 2004.
9. Burton A. Abciximab extends treatment window for stroke. Lancet Neurol 2003;2:390.
10. Wintermark M, Maeder P, Verdun FR et al. Using 80 kVp versus 120 kVp in perfusion CT measurement of regional cerebral blood flow. AJNR Am J Neuroradiol 2000;21:1881-4.
11. Lassen NA and Ingvar DH. Radioisotopic assessment of regional cerebral blood flow. Prog Nucl Med 1972;1:376-409.
12. Obrist WD, Thompson HK, Wang HS et al. Regional cerebral blood flowestimated by 133-xenon inhalation. Stroke 1975;6:245-56.
13. Yonas H, Good WF, Gur D et al. Mapping cerebral blood flow by xenon-enhanced computerized tomography: clinical experience. Radiology 1984;152:435-42.
14. Phelps ME, Hoffman EJ, Mullani NA et al. The application of annihilation coincidence detection to transaxial reconstruction tomography. J Nucl Med 1975;16:210-24.
15. Neirinckx RD, Canning LR, Piper IM et al. Technetium-99m d,1-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987;28:191-202.
16. Baron JC, Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001;11(suppl 1):2-8.
17. Marchal G, Beaudouin V, Rioux P et al. Prolonged persistence of substancial volumes of potentially viable brain tissue after stroke. Stroke 1996;27:599-606.
18. Furlan M, Marchal G, Viader F et al. Spontaneous neurological recovery after stroke and the fat of the ischemic penumbra. Ann Neurol 1996;40:216-26.
19. Heiss WD, Huber M, Fink GR et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992;12:193-203.
20. Wintermark M, Thiran JP, Maeder P et al. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol 2001;22:905-14.
21. Wintermark M, Reichhart M, Cuisenaire O et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002;33:2025-31.
22. Koenig, M, Klotz E, Luka B et al. Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke. Radiology 1998;209:85-93.
23. Konig, M, Klotz M, Heuser L. [Cerebral perfusion CT: theoretical aspects, methodical implementation and clinical experience in the diagnosis of ischemic cerebral infarction]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, 2000;172:210-8.
24. Mayer TE, Hamann GF, Baranczyk J et al. Dynamic CT perfusion imaging of acute stroke. AJNR Am J Neuroradiol 2000;21:14441-9.
25. Leys D, Pruvo JP, Godefroy O et al. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 1992;23: 317-24.
26. Barber PA, Demchuk AM, Hudon ME et al. Hyperacute sylvian fissure MCA "dot" sign: A CT marker of acute ischemia. Stroke 2001;32:84-8.
27. Tomura N, Uemura K, Inugami A et al. Early CT finding in cerebral infarction: obscuration of the lentiform nucleus. Radiology 1988;168:463-7.
28. Truwit CL, Barkovich AJ, Gean-Marton A et al. Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. Radiology 1990;176:801-6.
29. Schuierer G, Huk W. The unilateral hyperdense middle cerebral artery: an early CT-sign of embolism or thrombosis. Neuroradiology 1988;30:120-2.